
The aim of the study is to compare the accessibility to targeted zzso drugs in Slovenia and selected European zzso 

zzso of targeted zzso drugs was assessed by using their sales data, expressed in zzso per individual dying of the cancer for which the drug was zzso 

The time of introduction of targeted zzso drugs in Slovenia was in most cases similar to the comparison countries, except for zzso and zzso The zzso of targeted zzso drugs in Slovenia was in most cases lower than in other comparison zzso zzso had not been used in Slovenia until 2005, similar to France, Switzerland and zzso After 2003 the zzso of zzso in Slovenia started to rise zzso approaching the average zzso in comparison zzso 

The zzso of targeted zzso drugs in Slovenia was in most cases lower than in comparison zzso 

